There’s a lot to be optimistic about in the Healthcare sector as 1 analysts just weighed in on and Morphosys Ag (MOR) with bullish sentiments.
Morphosys Ag (MOR)
Berenberg Bank analyst Zhiqiang Shu maintained a Buy rating on Morphosys Ag on December 14 and set a price target of EUR140.00. The company’s shares closed last Friday at $28.40.
According to TipRanks.com, Shu is a 4-star analyst with an average return of 22.7% and a 76.5% success rate. Shu covers the Healthcare sector, focusing on stocks such as Black Diamond Therapeutics, Arcus Biosciences, and Seattle Genetics.
Currently, the analyst consensus on Morphosys Ag is a Moderate Buy with an average price target of $81.36.
See today’s analyst top recommended stocks >>
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
